Convatec Group Overview

  • Year Founded
  • 1978

Year Founded

  • Status
  • Public

  • Employees
  • 10,000

Employees

  • Stock Symbol
  • CTEC

Stock Symbol

  • Investments
  • 16

  • Share Price
  • $3.53
  • (As of Thursday Closing)

Convatec Group General Information

Description

Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute care hospital and chronic care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.

Contact Information

Formerly Known As
Bristol-Myers Squibb (ConvaTec)
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 7th Floor
  • 20 Eastbourne Terrace
  • London W2 6LG
  • England, United Kingdom
+44 01244
Primary Industry
Therapeutic Devices
Stock Exchange
LON
Vertical(s)
Corporate Office
  • 7th Floor
  • 20 Eastbourne Terrace
  • London W2 6LG
  • England, United Kingdom
+44 01244

Convatec Group Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Convatec Group Stock Performance

As of 19-Nov-2026, Convatec Group’s stock price is $3.53. Its current market cap is $6.73B with 1.91B shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.53 $3.57 $2.60 - $3.60 $6.73B 1.91B 8.34M $0.06

Convatec Group Financials Summary

As of 30-Jun-2026, Convatec Group has a trailing 12-month revenue of $2.49B.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 6,996,059 7,605,361 6,982,882 7,774,834
Revenue 2,491,000 2,439,000 2,289,000 2,142,400
EBITDA 449,000 513,000 536,000 450,300
Net Income 124,000 175,000 191,000 130,300
Total Assets 3,786,000 3,781,000 3,515,000 3,713,700
Total Debt 1,741,000 1,518,000 1,202,000 1,312,400
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Convatec Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Convatec Group‘s full profile, request access.

Request a free trial

Convatec Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, co
Therapeutic Devices
London, United Kingdom
10,000 As of 2026

Warsaw, IN
 

Mason, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Convatec Group Competitors (9)

One of Convatec Group’s 9 competitors is Zimmer Biomet Holdings, a Corporation company based in Warsaw, IN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zimmer Biomet Holdings Corporation Warsaw, IN
Orchid Orthopedic Solutions Private Equity-Backed Mason, MI
Medtronic Corporation Minneapolis, MN
Globus Medical Formerly VC-backed Audubon, PA
Joerns Healthcare Private Equity-Backed Charlotte, NC
You’re viewing 5 of 9 competitors. Get the full list »

Convatec Group Patents

Convatec Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025198867-A1 Brachytherapy composition and related methods Pending 18-Mar-2024
EP-4547171-A2 Coupling system for ostomy appliances Pending 01-Jul-2022
EP-4547171-A4 Coupling system for ostomy appliances Pending 01-Jul-2022
US-20250213384-A1 Coupling system for ostomy appliances Pending 01-Jul-2022
WO-2024006836-A2 Coupling system for ostomy appliances Inactive 01-Jul-2022 A61F5/443
To view Convatec Group’s complete patent history, request access »

Convatec Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Convatec Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Convatec Group‘s full profile, request access.

Request a free trial

Convatec Group Investments & Acquisitions (16)

Convatec Group’s most recent deal was a Merger/Acquisition with Livramedom for . The deal was made on 17-Sep-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Livramedom 17-Sep-2024 Merger/Acquisition Elder and Disabled Care
Starlight Science 18-Apr-2023 Merger/Acquisition Other Devices and Supplies
BlueWind Medical 04-May-2022 Later Stage VC Therapeutic Devices
Triad Life Sciences 24-Feb-2022 Merger/Acquisition Biotechnology
Patient Care Medical 01-Dec-2021 Merger/Acquisition Distributors/Wholesale
You’re viewing 5 of 16 investments and acquisitions. Get the full list »

Convatec Group ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

10.51 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Supplies

Subindustry

of 60

Rank

Percentile

To view Convatec Group’s complete esg history, request access »

Convatec Group Exits (2)

Convatec Group’s most recent exit was on 01-Sep-2017 from Personally Delivered. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Personally Delivered 01-Sep-2017 Completed
Unora 01-Jun-2012 Buyout/LBO Completed
  • 3 buyers
To view Convatec Group’s complete exits history, request access »

Convatec Group Affiliates

Subsidiaries (19)

Name Industry Location Year Founded
Convatec Nap Deeside, United Kingdom 2023
Starlight Science Deeside, United Kingdom 2022
Patient Care Medical Austin, TX 2010
SureCalm Healthcare Basingstoke, United Kingdom 2010
AbViser Medical Montgomery, NJ 2010
You’re viewing 5 of 19 affiliates. Get the full list.  »

Convatec Group FAQs

  • When was Convatec Group founded?

    Convatec Group was founded in 1978.

  • Where is Convatec Group headquartered?

    Convatec Group is headquartered in London, United Kingdom.

  • What is the size of Convatec Group?

    Convatec Group has 10,000 total employees.

  • What industry is Convatec Group in?

    Convatec Group’s primary industry is Therapeutic Devices.

  • Is Convatec Group a private or public company?

    Convatec Group is a Public company.

  • What is Convatec Group’s stock symbol?

    The ticker symbol for Convatec Group is CTEC.

  • What is the current stock price of Convatec Group?

    As of 19-Nov-2026 the stock price of Convatec Group is $3.53.

  • What is the current market cap of Convatec Group?

    The current market capitalization of Convatec Group is $6.73B.

  • What is Convatec Group’s current revenue?

    The trailing twelve month revenue for Convatec Group is $2.49B.

  • Who are Convatec Group’s competitors?

    Zimmer Biomet Holdings, Orchid Orthopedic Solutions, Medtronic, Globus Medical, and Joerns Healthcare are some of the 9 competitors of Convatec Group.

  • What is Convatec Group’s annual earnings per share (EPS)?

    Convatec Group’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process